ASIA honors SCI researchers with 2012 Apple Award

NewsGuard 100/100 Score

American Spinal Injury Association (ASIA) has awarded its 2012 Apple Award to the article by Mark Nash, PhD, et al, entitled, "Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter controlled trial." The article, (doi:10.1016/j.apmr.2010.06.029) which was published in Archives of Physical Medicine and Rehabilitation in March 2011, is based on a study conducted in spinal cord injury (SCI) research centers in Florida, New York, New Jersey and California. The study was supported by a SCI Collaborative Research Project (grant no. H133A111105) from the National Institute on Disability and Rehabilitation Research, and Kos Pharmaceuticals.

Dr. Nash accepted the award at the annual ASIA meeting on behalf of the authors. Drs. Nash, John Lewis, and Armando J. Mendez are affiliated with the University of Miami, Miller School of Medicine, Miami, Florida. Their co-authors are Trevor A. Dyson-Hudson, MD, of Kessler Foundation, West Orange, NJ, Yaga Szlachcic, MD, and Florence Yee, PharmD of Rancho Los Amigos National Research Center, Downey, CA, and Ann M. Spungen, EdD, and William A. Bauman, MD, of the James Peters VA Medical Center, Bronx, NY. Dr. Dyson-Hudson acknowledged the many challenges to carrying out a multi-center clinical trial. "However," he commented, "results from rigorously controlled collaborative studies like this one provide the necessary evidence to support the usage of interventions in persons with SCI and provide the foundation for clinical guidelines in this population."

Source: Kessler Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Are we eating what's really good for us? New insights into macronutrients and chronic disease